Anzeige
Mehr »
Sonntag, 10.08.2025 - Börsentäglich über 12.000 News

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A416YS | ISIN: US00901B3033 | Ticker-Symbol: HXB
Lang & Schwarz
10.08.25 | 19:04
0,073 Euro
0,00 % 0,000
Branche
Biotechnologie
Aktienmarkt
Sonstige
1-Jahres-Chart
AIM IMMUNOTECH INC Chart 1 Jahr
5-Tage-Chart
AIM IMMUNOTECH INC 5-Tage-Chart
RealtimeGeldBriefZeit
0,0660,08019:05

Aktuelle News zur AIM IMMUNOTECH Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
MiAIM ImmunoTech Inc.: AIM ImmunoTech's Oncology Drug Ampligen to Be Featured in Key Presentations and Abstract at the International 5th Annual Marie Sklodowska-Curie Symposium on Cancer Research and Care (MSCI MSCS-2025)130There will be presentations on the latest positive progress from AIM's clinical program in pancreatic cancer, the positive therapeutic effects of AIM's drug Ampligen on multiple cancer types, and...
► Artikel lesen
MoAIM ImmunoTech Inc.: AIM ImmunoTech Builds Positive Momentum and Reiterates Focus on Driving Ampligen Clinical Development Toward Pancreatic Cancer Approval130Primary focus on pancreatic cancer Mid-year report of Ampligen® (rintatolimod) in combination with AstraZeneca's Imfinzi® (durvalumab) for the treatment of pancreatic cancer demonstrates positive...
► Artikel lesen
31.07.AIM ImmunoTech Inc.: AIM ImmunoTech Announces Closing of $8.0 Million Public Offering1
29.07.AIM ImmunoTech stock plunges after pricing $8 million public offering5
29.07.AIM ImmunoTech prices $8 million public offering at $4.00 per share3
AIM IMMUNOTECH Aktie jetzt für 0€ handeln
29.07.Pre-market Movers: DURECT Corporation, Salarius Pharmaceuticals, ScanTech AI Systems, AIM ImmunoTech, Bakkt Holdings485OTTAWA (dpa-AFX) - The following are some of the stocks making big moves in Tuesday's pre-market trading (as of 07.25 A.M. ET).In the Green DURECT Corporation (DRRX) is up over 267% at $2.03. Salarius...
► Artikel lesen
29.07.AIM ImmunoTech announces pricing of $8 million public offering; shares down over 50%2
29.07.AIM ImmunoTech Inc.: AIM ImmunoTech Announces Pricing of $8.0 Million Public Offering135OCALA, Fla., July 29, 2025 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (the "Company"), today announced the pricing of a public offering of an aggregate of 2,000,000 shares of its...
► Artikel lesen
28.07.Why Is Micro-Cap AIM ImmunoTech Stock Surging?2
28.07.AIM ImmunoTech Inc. - 8-K, Current Report3
28.07.AIM ImmunoTech Inc.: AIM ImmunoTech Reports Positive Mid-year Safety and Efficacy Data from Phase 2 Study Evaluating Ampligen (rintatolimod) in Combination with AstraZeneca's Imfinzi (durvalumab) for the Treatment of Pancreatic ...188OCALA, Fla., July 28, 2025 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) ("AIM" or the "Company") today reported positive data in a mid-year update from the ongoing Phase 2 clinical...
► Artikel lesen
15.07.AIM ImmunoTech Inc. - S-8, Securities to be offered to employees in employee benefit plans2
15.07.AIM ImmunoTech Inc. - S-1/A, General form for registration of securities1
02.07.AIM ImmunoTech Inc.: AIM ImmunoTech Announces Recent Presentation on the Potential of Private-Public Partnerships for the Development of Oncology Therapies2
20.06.AIM ImmunoTech Inc. - 8-K, Current Report2
20.06.AIM ImmunoTech Inc.: AIM ImmunoTech Announces NYSE American Notice of Noncompliance With Minimum Stockholders' Equity Requirements153NYSE American previously issued similar warning for same matter and issued the new notice because the deficiency remains as of March 31, 2025 AIM has until June 11, 2026 to regain compliance OCALA...
► Artikel lesen
17.06.AIM ImmunoTech resumes trading on NYSE American2
17.06.AIM ImmunoTech Inc.: AIM ImmunoTech Resumes Trading on NYSE American587OCALA, Fla., June 17, 2025 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) ("AIM" or the "Company") today announced that its common stock has resumed trading on the NYSE American under...
► Artikel lesen
13.06.XFRA HXB,J4T: AUSSETZUNG/SUSPENSION204DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILAIM IMMUNOTEC.NEW...
► Artikel lesen
13.06.XFRA NEW INSTRUMENTS AVAILABLE ON 13.06.2025307The following instruments on XETRA do have their first trading 13.06.2025 Die folgenden Instrumente in XETRA haben ihren ersten Handelstag 13.06.2025 Aktien 1 AU0000095721 DUG Technology Ltd. 2...
► Artikel lesen
Weiter >>
57 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,2